Adpharmasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-07-03
Share capital
50 000,00 PLN
Activity description

Adpharma is a Polish pharmaceutical and biotechnology company with 40 years of experience, focusing on the development of prescription and over-the-counter medications, dietary supplements, dermocosmetics, and medical devices. The company offers high-quality therapeutic products addressing chronic diseases across several therapeutic areas and holds 256 patents in the pharmaceutical field. Adpharma's products are available in numerous markets worldwide, with an extensive portfolio of approximately 900 items.

Registered address
ul. Mariana Adamkiewicza 6, 05-152 Pieńków, Poland
Website
adamed.comWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-79515-85176-CWWHW-23

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 5.60mMedianUSD 1.75mAverageUSD 5.00m
Net profit
This companyUSD -953.44kMedianUSD 17.49kAverageUSD 85.24k
Operating costs
This companyUSD 6.50mMedianUSD 1.72mAverageUSD 4.85m
Assets
This companyUSD 1.26mMedianUSD 495.38kAverageUSD 1.71m

News

Paweł Roszczyk in “XYZ”: over 100 million PLN for Italy, 1.5 billion PLN for Poland

Relationship and mindfulness can save lives. Adamed Foundation honored at the World Suicide Prevention Day conference

Dr n. med. Małgorzata Adamkiewicz in “Rzeczpospolita”: stable law and knowledge transfer from universities support innovations

Dr n. med. Małgorzata Adamkiewicz for “Forbes”: The Polish economy needs innovation

Michał Adamkiewicz for “Forbes”: What can Poland learn from Silicon Valley?

From photoreactor to intelligent glove. The 12th Adamed SmartUp science camp has ended

Industry

Bank accounts

Registered as a VAT taxpayer on 2006-06-23. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Public sector contracts

Adpharma is the contractor in 3 public sector contracts, worth PLN 485.95 in total. They were signed with 2 public buyers. The largest number (2) were signed with Akademia Wychowania Fizycznego Im.Eugeniusza Piaseckiego w Poznaniu.

Public buyerValue
Akademia Wychowania Fizycznego Im.Eugeniusza Piaseckiego w PoznaniuPLN 271.87
Przychodnia Rejonowa w ProchowicachPLN 119.97
Akademia Wychowania Fizycznego Im.Eugeniusza Piaseckiego w PoznaniuPLN 94.11

National Health Fund (NFZ) contracts

Adpharma has been an NFZ healthcare provider since 2023. In 2026 it is performing 2 contracts with a total value of USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Inne usługi realizowane w aptekachłódzkie2USD 0.00

Trademarks

Adpharma holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2020.

MarkProtected until
APTEKA DLA RODZINYApr 9, 2030

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Małgorzata Adamkiewicz – Attorney-in-fact (joint)
Grzegorz Ludwik Chełmicki – Management Board Member
Dariusz Wiesław Deja – Management Board Member
Małgorzata Guzy – Attorney-in-fact (joint)
Tomasz Krzak – Management Board Member

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company. In the case of a one-person management board, one member of the management board or a commercial proxy is authorized to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
Adamed Pharma S.A.
Adamed Pharma S.A.
1,000$13,506.21100%

Beneficial owners

Person

Competitors

Name
NOYO Pharmsp. z o.o.
APIS Farmacjasp. z o.o.
Farmjugsp. z o.o.
Fragalsp. z o.o.
Modrzewscysp. j.
Farmjug Agsp. z o.o.
Sendpol24sp. z o.o.
Pikadasp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Mediatessp. z o.o.

Change history

DateEvent
2019-02-27Address change
2018-08-31Address change
2015-10-28PKD change
2013-11-19PKD change
2006-09-25Address change

FAQ

Last updated: 2026-10-07